Articles

Zimmer faces new threat to dominance

Warsaw-based Zimmer Holdings Inc. has enjoyed eight years as the giant in the industry of selling knee- and hip-replacement implants to hospitals. But now it faces a challenge from Johnson & Johnson.

Read More

Two wins to bring Lilly modest sales

Finally, some new revenue. Eli Lilly and Co. will enjoy modest new sales later this year after U.S. regulators approved a new diabetes drug developed by a partner company, and another company nears approval on a drug that will produce royalties for the Indianapolis-based drugmaker.

Read More

Fee could feed $100M to hospitals

Indiana hospitals could pull in more than $100 million a year from the federal government under a new assessment fee included in the state’s 2011 budget bill.

Read More